Routine Blood Count and Chemistry can predict AD dementia risk up to Ten years Ahead
Routine Blood count and chemistry, done for various other reasons, may enclose information concerning future risk for AD dementia. Using ML and AI sophisticated tools can facilitate the use of routine blood exams as a screening tool for AD dementia risk assessment.
Authors
- Chen Hajaj (ORCID: https://orcid.org/0000-0001-9940-5654)
- Amir Glik
- Hayim Raclaw
- Orit Raphaeli (ORCID: https://orcid.org/0000-0001-7465-9674)
- Keshet Prado
- Roy Kait
- Omry Arbiv
- Anat Goldstein
- Ofri Kait
Institutions
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Israel Ministry of Health (IL)
- Public Health Ontario (CA)
- Ariel University (IL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102512
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00